Table 1

Baseline characteristics of non-diabetic study participants

NGTPrediabetesP value
TotalIFGIGTEHbA1c
N18364610195416963848
Age (years)55.5±6.957.8±7.458.2±7.658.9±7.758.0±7.4<0.001
Female, n (%)1235 (67.3)3116 (67.6)1240 (63.5)1150 (67.8)2661 (69.2)0.4
Smoking, n (%)286 (15.6)747 (16.2)340 (17.4)230 (13.6)618 (16.1)0.3
Drinking, n (%)485 (26.4)1211 (26.3)563 (28.8)414 (24.4)965 (25.1)0.5
BMI (kg/m2)24.8±3.2 25.7±3.426.1±3.426.2±3.425.8±3.4<0.001
FPG (mmol/L)5.0 (4.8–5.3)5.5 (5.2–5.8)5.9 (5.7–6.2)5.6 (5.2–6.0)5.5 (5.2–5.8)<0.001
2hPG (mmol/L)6.0 (5.2–6.7)7.1 (6.0–8.4)7.5 (6.3–8.7)8.8 (8.2–9.6)6.9 (5.9–8.2)<0.001
HbA1c (%)5.4 (5.2–5.5)5.9 (5.7–6.1)5.9 (5.7–6.1)5.9 (5.6–6.1)5.9 (5.8–6.1)<0.001
SBP (mm Hg)126.8±16.7131.6±16.5133.9±16.2133.7±16.6131.6±16.6<0.001
DBP (mm Hg)75.4±13.975.7±11.576.5±9.776.6±12.375.3±10.70.3
TC (mmol/L)5.0 (4.5–5.6)5.2 (4.7–5.9)5.3 (4.7–5.9)5.2 (4.7–5.9)5.3 (4.7–5.9)<0.001
TG (mmol/L)1.2 (0.8–1.6)1.3 (1.0–1.9)1.4 (1.0–2.0)1.5 (1.1–2.1)1.3 (1.0–1.9)<0.001
HDL-C (mmol/L)1.5 (1.2–1.7)1.4 (1.2–1.7)1.4 (1.2–1.6)1.4 (1.2–1.6)1.4 (1.2–1.7)<0.001
LDL-C (mmol/L)3.0 (2.6–3.5)3.2 (2.7–3.8)3.2 (2.7–3.8)3.2 (2.7–3.8)3.3 (2.8–3.8)<0.001
eGFR (mL/min per 1.73 m2)96.5 (87.9–102.7)95.4 (86.2–101.6)94.7 (85.8–101.4)94.2 (84.7–101.0)95.4 (86.4–101.6)<0.001
  • Data were expressed as mean±SD or median (IQR 25%±75%) for continuous variables and as number (percentage) for categorical variables. P from t test, Kruskal-Wallis test or chi-square test, total prediabetes compared with NGT.

  • BMI, body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; EHbA1c, elevated glycated hemoglobin A1c; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; 2hPG, 2-hour plasma glucose; IFG, impaired fasting glucose; IGT, impairedglucose tolerance; LDL-C, low-density lipoprotein cholesterol; NGT, normal glucose tolerance; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.